Onder Sirikci
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Onder Sirikci has a total of 30 co-authors. Here are the top co-authors by number of shared publications:
- Goncagul Haklar
Department of Biochemistry, School of Medicine, Marmara University, Istanbul, Turkey
6 shared publications - Rana Turkal
Marmara University Pendik Education and Research Hospital
3 shared publications - Tülay Çevlik
Marmara University Pendik Education and Research Hospital
3 shared publications - Ali Yaman
Department of Biochemistry, School of Medicine, Marmara University, Istanbul, Turkey
2 shared publications - Hulya Gozu
Department of Endocrinology and Metabolism Marmara University School of Medicine Istanbul Turkey
2 shared publications - Ahmet Faruk Tekin
School of Medicine, Marmara University
1 shared publication
Latest Publications
- 18 February 2026
- Published by SAGE Publications in Journal of Intensive Care Medicine
Thrombin Generation Measurement: A Novel Diagnostic and Prognostic Approach for Identifying Early-Stage Disseminated Intravascular Coagulation in Individuals with Sepsis
Background: Disseminated intravascular coagulation (DIC) is a complex hemostatic disorder characterized by simultaneous thrombosis and bleeding and is frequently observed in sepsis. Traditional coagulation assays such as prothrombin time (PT) and activated partial thromboplastin time (aPTT) primarily assess the initiation of clot formation but fail to capture the dynamic balance between procoagulant and anticoagulant forces. The thrombin generation (TG) assay provides a more comprehensive evaluation of coagulation, incorporating both propagation and decay phases, and may offer additional insight into sepsis-associated coagulopathy. This study investigated the diagnostic and prognostic utility of TG parameters across graded stages of DIC in septic intensive care unit (ICU) patients. Methods: In this prospective observational study, 53 adult septic ICU patients contributed 151 plasma samples obtained longitudinally. Patients were classified as non-DIC, non-overt DIC, or overt DIC according to International Society on Thrombosis and Haemostasis criteria. Standard coagulation parameters and TG profiles were measured. Associations with DIC severity were examined using cumulative link mixed models with patient-level random effects. Sensitivity analyses explored transition-specific TG behavior. ICU mortality was evaluated using multivariable logistic regression and ROC analysis. Results: In univariate analyses, both conventional coagulation markers and TG parameters were associated with increasing DIC severity. In the final multivariable model, prolonged PT and aPTT, elevated D-dimer, and lower platelet count were the strongest independent predictors of DIC severity, whereas StartTail provided complementary kinetic information. Longitudinal analyses demonstrated progressive prolongation of StartTail and attenuation of reverse velocity index with advancing DIC stage and increasing SOFA scores, indicating worsening dysregulation of thrombin inactivation. Conclusion: TG parameters, particularly late-phase kinetic features, reflect dynamic and stage-specific dysregulation of coagulation in sepsis-associated DIC. Although TG measures do not outperform conventional coagulation tests, they provide complementary mechanistic insight into thrombin regulation and consumptive coagulopathy. Larger multicenter studies are warranted to validate these findings.
- 18 February 2026
- Published by SAGE Publications in Journal of Intensive Care Medicine
Thrombin Generation Measurement: A Novel Diagnostic and Prognostic Approach for Identifying Early-Stage Disseminated Intravascular Coagulation in Individuals with Sepsis
Background: Disseminated intravascular coagulation (DIC) is a complex hemostatic disorder characterized by simultaneous thrombosis and bleeding and is frequently observed in sepsis. Traditional coagulation assays such as prothrombin time (PT) and activated partial thromboplastin time (aPTT) primarily assess the initiation of clot formation but fail to capture the dynamic balance between procoagulant and anticoagulant forces. The thrombin generation (TG) assay provides a more comprehensive evaluation of coagulation, incorporating both propagation and decay phases, and may offer additional insight into sepsis-associated coagulopathy. This study investigated the diagnostic and prognostic utility of TG parameters across graded stages of DIC in septic intensive care unit (ICU) patients. Methods: In this prospective observational study, 53 adult septic ICU patients contributed 151 plasma samples obtained longitudinally. Patients were classified as non-DIC, non-overt DIC, or overt DIC according to International Society on Thrombosis and Haemostasis criteria. Standard coagulation parameters and TG profiles were measured. Associations with DIC severity were examined using cumulative link mixed models with patient-level random effects. Sensitivity analyses explored transition-specific TG behavior. ICU mortality was evaluated using multivariable logistic regression and ROC analysis. Results: In univariate analyses, both conventional coagulation markers and TG parameters were associated with increasing DIC severity. In the final multivariable model, prolonged PT and aPTT, elevated D-dimer, and lower platelet count were the strongest independent predictors of DIC severity, whereas StartTail provided complementary kinetic information. Longitudinal analyses demonstrated progressive prolongation of StartTail and attenuation of reverse velocity index with advancing DIC stage and increasing SOFA scores, indicating worsening dysregulation of thrombin inactivation. Conclusion: TG parameters, particularly late-phase kinetic features, reflect dynamic and stage-specific dysregulation of coagulation in sepsis-associated DIC. Although TG measures do not outperform conventional coagulation tests, they provide complementary mechanistic insight into thrombin regulation and consumptive coagulopathy. Larger multicenter studies are warranted to validate these findings.
- Open Access
- 1 January 2026
- Published by Kare Publishing in International Journal of Medical Biochemistry
- Vol. 9 (4) , 232-241
Interpretation of heterophile-blocking tube results in thyroid function testing using analytical change limits: An exploratory study of clinically discordant cases
- 1 January 2026
- Published by Kare Publishing in International Journal of Medical Biochemistry
- Vol. 9 (4) , 232-241
Open AccessInterpretation of heterophile-blocking tube results in thyroid function testing using analytical change limits: An exploratory study of clinically discordant cases
- 3 May 2023
- Published by Caleo in Turkish Society of Clinical Biochemistry
- Vol. 21 (1) , 054-063
Prostat Kanseri Tanısında Mevcut Biyobelirteçler ve İdrar Sarkozini
Amaç: Prostat kanseri, erkeklerde kansere bağlı ölümler arasında ikinci sırada yer almaktadır. PCa tanısında parmakla rektal muayene, serum PSA ve biyopsi kullanılan temel araçlardır. PSA’nın özgüllüğünün düşük olması gereksiz biyopsilere neden olmaktadır. Bu nedenle özgüllüğü yüksek olan biyobelirteçlere ihtiyaç vardır. Sarkozinin prostat kanseri tanısındaki rolüne ilişkin çalışmalar mevcuttur. Ancak çalışma dizaynlarındaki farklılar nedeniyle sonuçlar karşılaştırılabilir değildir. Çalışmada idrar sarkozin düzeyi ile proPSA’nın PCa tanısındaki performansını mevcut biyobelirteçlerle karşılaştırmayı amaçladık. Gereç ve Yöntem: Prostat biyopsisi yapılan toplam 105 hasta çalışmaya alındı. Bu hastaların PSA, fPSA, %fPSA, p2PSA, prostat volümü ve phi ile idrarda sarkozin düzeyleri ölçülerek karşılaştırıldı. Bu parametrelerin tanı koyma performansları ROC eğrisi analizleriyle değerlendirildi ve kesme değerleri, duyarlılık ve özgüllükleri karşılaştırıldı. Ayrıca PCa hastaları Gleason skorlarına göre (<7 ve ≥7) iki gruba ayrılarak bu parametrelerin dağılımları incelendi. Bulgular: Serum PSA, p2PSA ve idrar sarkozin düzeyleri, biyopsi pozitif grupta daha yüksek olmasına rağmen istatistiksel olarak farklı değildi. Ancak phi değeri biyopsi pozitif grupta anlamlı şekilde daha yüksek, %fPSA ve PV değerleri ise daha düşüktü. Sarkozin ve PSA, GS≥ 7 grubunda anlamlı yüksekti. Belirteçlerin duyarlılıklarının %90 olduğu kesme değerlerinde sırasıyla %fPSA, PV ve phi’nin özgüllükleri PSA’dan yüksek idi. Sonuç: İdrar sarkozin’in PCa tanısında tek başına yeterli olmadığı, GS≥7 olduğu riskli PCa hastalarında kullanılabileceği tespit edildi. Phi, %fPSA ve PV’nin PCa tanısında PSA’dan daha iyi oldukları görüldü. Bunun yanı sıra PV’nin phi’nin özgüllüğünü iyileştirebileceği tespit edildi.
- 3 May 2023
- Published by Caleo in Turkish Society of Clinical Biochemistry
- Vol. 21 (1) , 054-063
Prostat Kanseri Tanısında Mevcut Biyobelirteçler ve İdrar Sarkozini
Amaç: Prostat kanseri, erkeklerde kansere bağlı ölümler arasında ikinci sırada yer almaktadır. PCa tanısında parmakla rektal muayene, serum PSA ve biyopsi kullanılan temel araçlardır. PSA’nın özgüllüğünün düşük olması gereksiz biyopsilere neden olmaktadır. Bu nedenle özgüllüğü yüksek olan biyobelirteçlere ihtiyaç vardır. Sarkozinin prostat kanseri tanısındaki rolüne ilişkin çalışmalar mevcuttur. Ancak çalışma dizaynlarındaki farklılar nedeniyle sonuçlar karşılaştırılabilir değildir. Çalışmada idrar sarkozin düzeyi ile proPSA’nın PCa tanısındaki performansını mevcut biyobelirteçlerle karşılaştırmayı amaçladık. Gereç ve Yöntem: Prostat biyopsisi yapılan toplam 105 hasta çalışmaya alındı. Bu hastaların PSA, fPSA, %fPSA, p2PSA, prostat volümü ve phi ile idrarda sarkozin düzeyleri ölçülerek karşılaştırıldı. Bu parametrelerin tanı koyma performansları ROC eğrisi analizleriyle değerlendirildi ve kesme değerleri, duyarlılık ve özgüllükleri karşılaştırıldı. Ayrıca PCa hastaları Gleason skorlarına göre (<7 ve ≥7) iki gruba ayrılarak bu parametrelerin dağılımları incelendi. Bulgular: Serum PSA, p2PSA ve idrar sarkozin düzeyleri, biyopsi pozitif grupta daha yüksek olmasına rağmen istatistiksel olarak farklı değildi. Ancak phi değeri biyopsi pozitif grupta anlamlı şekilde daha yüksek, %fPSA ve PV değerleri ise daha düşüktü. Sarkozin ve PSA, GS≥ 7 grubunda anlamlı yüksekti. Belirteçlerin duyarlılıklarının %90 olduğu kesme değerlerinde sırasıyla %fPSA, PV ve phi’nin özgüllükleri PSA’dan yüksek idi. Sonuç: İdrar sarkozin’in PCa tanısında tek başına yeterli olmadığı, GS≥7 olduğu riskli PCa hastalarında kullanılabileceği tespit edildi. Phi, %fPSA ve PV’nin PCa tanısında PSA’dan daha iyi oldukları görüldü. Bunun yanı sıra PV’nin phi’nin özgüllüğünü iyileştirebileceği tespit edildi.
- Open Access
- 24 August 2022
- Published by Walter de Gruyter GmbH in Turkish Journal of Biochemistry
- Vol. 47 (5) , 686-689
A case of falsely elevated D-dimer result
Objectives: Heterophile antibodies can cause interferences in immunometric assays. While many tests are shown to be affected by interference from heterophilic antibodies, the D-dimer test has rarely been reported to be affected. With this case, we report an elevated D-dimer measurement which was not compatible with the clinical presentation. Case presentation: A 41-year-old patient who was admitted to hospital with heart palpitations had a D-dimer elevation irrelevant to his clinical condition. D-dimer measurements were repeated in new samples directly and after being treated in heterophilic blocking tube with two different reagent lots of a latex-based automated immunoturbidimetric assay and an immunoturbidometric assay. D-dimer values were normalized (0–0.5 mg/L) when we used a new lot of reagent on the same instrument or measured by an immunoturbidometric method on the chemistry analyzer. After treatment with HBT, all samples revealed D-dimer results within the reference ranges. Conclusions: The presence of heterophile antibodies in a sample should be considered when an elevated D-dimer value that is not compatible with the clinical presentation is encountered. Apart from the patient’s HA’s causing false results, sporadic susceptibility of the reagents should also be kept in mind as a possibility.
- 24 August 2022
- Published by Walter de Gruyter GmbH in Turkish Journal of Biochemistry
- Vol. 47 (5) , 686-689
Open AccessA case of falsely elevated D-dimer result
Objectives: Heterophile antibodies can cause interferences in immunometric assays. While many tests are shown to be affected by interference from heterophilic antibodies, the D-dimer test has rarely been reported to be affected. With this case, we report an elevated D-dimer measurement which was not compatible with the clinical presentation. Case presentation: A 41-year-old patient who was admitted to hospital with heart palpitations had a D-dimer elevation irrelevant to his clinical condition. D-dimer measurements were repeated in new samples directly and after being treated in heterophilic blocking tube with two different reagent lots of a latex-based automated immunoturbidimetric assay and an immunoturbidometric assay. D-dimer values were normalized (0–0.5 mg/L) when we used a new lot of reagent on the same instrument or measured by an immunoturbidometric method on the chemistry analyzer. After treatment with HBT, all samples revealed D-dimer results within the reference ranges. Conclusions: The presence of heterophile antibodies in a sample should be considered when an elevated D-dimer value that is not compatible with the clinical presentation is encountered. Apart from the patient’s HA’s causing false results, sporadic susceptibility of the reagents should also be kept in mind as a possibility.
- Open Access
- 13 August 2021
- Published by Hindawi Limited in International Journal of Endocrinology
- Vol. 2021, 1-11
The Association of Thyroid Hormone Changes with Inflammatory Status and Prognosis in COVID-19
Background. COVID-19 infection may have multiorgan effects in addition to effects on the lungs and immune system. Recently, studies have found thyroid function abnormalities in COVID-19 cases which were interpreted as euthyroid sick syndrome (ESS) or destructive thyroiditis. Therefore, in this study, we aimed to evaluate the thyroid function status and thyroid autoimmunity in COVID-19 patients. Material and Method. 205 patients were included. The medical history and laboratory parameters at admission were collected from medical records. Serum thyroid-stimulating hormone (TSH), free thyroxine (FT4), free triiodothyronine (FT3), thyroid peroxidase antibody, and thyroglobulin antibody were measured, and patients were classified according to thyroid function status. Results. 34.1% of the patients were euthyroid. Length of hospitalization ( ), rate of oxygen demand ( ), and intensive care unit (ICU) admission ( ) were lower, and none of the euthyroid patients died. 108 (52.6%) patients were classified to have ESS, 57 were classified as mild, and 51 were moderate. The inflammatory parameters were higher in patients with moderate ESS. In cluster analysis, a high-risk group with a lower median FT3 value (median = 2.34 ng/L; IQR = 0.86), a higher median FT4 value (median = 1.04 ng/dL; IQR = 0.33), and a lower median TSH value (median = 0.62 mIU/L; IQR = 0.59) included 8 of 9 died patients and 25 of the 31 patients that were admitted to ICU. Discussion. Length of hospitalization, oxygen demand, ICU admission, and mortality were lower in euthyroid patients. Moreover, none of the euthyroid patients died. In conclusion, evaluation of thyroid function tests during COVID-19 infection may give information about the prognosis of disease.
- 13 August 2021
- Published by Hindawi Limited in International Journal of Endocrinology
- Vol. 2021, 1-11
Open AccessThe Association of Thyroid Hormone Changes with Inflammatory Status and Prognosis in COVID-19
Background. COVID-19 infection may have multiorgan effects in addition to effects on the lungs and immune system. Recently, studies have found thyroid function abnormalities in COVID-19 cases which were interpreted as euthyroid sick syndrome (ESS) or destructive thyroiditis. Therefore, in this study, we aimed to evaluate the thyroid function status and thyroid autoimmunity in COVID-19 patients. Material and Method. 205 patients were included. The medical history and laboratory parameters at admission were collected from medical records. Serum thyroid-stimulating hormone (TSH), free thyroxine (FT4), free triiodothyronine (FT3), thyroid peroxidase antibody, and thyroglobulin antibody were measured, and patients were classified according to thyroid function status. Results. 34.1% of the patients were euthyroid. Length of hospitalization ( ), rate of oxygen demand ( ), and intensive care unit (ICU) admission ( ) were lower, and none of the euthyroid patients died. 108 (52.6%) patients were classified to have ESS, 57 were classified as mild, and 51 were moderate. The inflammatory parameters were higher in patients with moderate ESS. In cluster analysis, a high-risk group with a lower median FT3 value (median = 2.34 ng/L; IQR = 0.86), a higher median FT4 value (median = 1.04 ng/dL; IQR = 0.33), and a lower median TSH value (median = 0.62 mIU/L; IQR = 0.59) included 8 of 9 died patients and 25 of the 31 patients that were admitted to ICU. Discussion. Length of hospitalization, oxygen demand, ICU admission, and mortality were lower in euthyroid patients. Moreover, none of the euthyroid patients died. In conclusion, evaluation of thyroid function tests during COVID-19 infection may give information about the prognosis of disease.
- 1 January 2017
- Published by Elsevier in Journal of Infection and Chemotherapy
- Vol. 23 (1) , 17-22
The diagnostic value of soluble urokinase plasminogen activator receptor (suPAR) compared to C-reactive protein (CRP) and procalcitonin (PCT) in children with systemic inflammatory response syndrome (SIRS)
- 1 January 2017
- Published by Elsevier in Journal of Infection and Chemotherapy
- Vol. 23 (1) , 17-22
The diagnostic value of soluble urokinase plasminogen activator receptor (suPAR) compared to C-reactive protein (CRP) and procalcitonin (PCT) in children with systemic inflammatory response syndrome (SIRS)